“We tested the hypothesis that therapy with valsartan , an angiotensin receptor blocker and amlodipine, an antioxidant calcium channel blocker will reduce oxidative stress and the plasma levels of asymmetric dimethylarginine ( ADMA), an endogenous inhibitor of nitric oxide synthase.”